| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 3.886 | 5.673 | - | - | 0 | 0 | 6.570 | 12.565 |
| Total Income - EUR | 0 | 0 | 3.886 | 5.673 | - | - | 0 | 0 | 6.571 | 12.565 |
| Total Expenses - EUR | 0 | 19.328 | 1.081 | 4.502 | - | - | 0 | 0 | 25.135 | 3.812 |
| Gross Profit/Loss - EUR | 0 | -19.328 | 2.805 | 1.171 | - | - | 0 | 0 | -18.565 | 8.753 |
| Net Profit/Loss - EUR | 0 | -19.328 | 2.689 | 1.001 | - | - | 0 | 0 | -18.565 | 8.753 |
| Employees | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. San S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.441 | 7.631 | 7.502 | 5.240 | - | - | 2.932 | 2.941 | 0 | 0 |
| Current Assets | 15.446 | 320 | 2.323 | 827 | - | - | 3.891 | 3.903 | 7.110 | 17.021 |
| Inventories | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 |
| Receivables | 15.448 | 320 | 2.186 | 727 | - | - | 3.797 | 3.809 | 2.022 | 5.026 |
| Cash | -2 | 0 | 137 | 100 | - | - | 94 | 94 | 5.089 | 11.995 |
| Shareholders Funds | -15.946 | -35.111 | -46.778 | -44.918 | - | - | -41.233 | -41.361 | -86.775 | -77.537 |
| Social Capital | 45 | 45 | 44 | 43 | - | - | 40 | 41 | 40 | 40 |
| Debts | 73.366 | 76.253 | 78.602 | 79.659 | - | - | 75.029 | 75.262 | 93.885 | 94.558 |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. San S.r.l.